Acorda Therapeutics Inc (ACOR.O)

ACOR.O on Nasdaq

35.35USD
9 Feb 2016
Change (% chg)

-- (--)
Prev Close
$35.35
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
726,265
52-wk High
$43.63
52-wk Low
$25.50

ACOR.O

Chart for ACOR.O

About

Acorda Therapeutics, Inc. is a biopharmaceutical company engaged in the identification, development and commercialization of therapies that restore neurological function and treat patients with neurological disorders. The Company’s markets three United States Food and Drug Administration (FDA)-approved therapies, including... (more)

Overall

Beta: 1.66
Market Cap(Mil.): $1,525.54
Shares Outstanding(Mil.): 43.16
Dividend: --
Yield (%): --

Financials

  ACOR.O Industry Sector
P/E (TTM): 736.15 36.59 38.48
EPS (TTM): 0.05 -- --
ROI: 0.23 6.96 14.34
ROE: 0.40 9.03 15.17
Search Stocks

Acorda to buy Finland's Biotie for $363 million

HELSINKI U.S. biotechnology company Acorda Therapeutics Inc. announced on Tuesday an agreed $363 million cash bid for all of the shares in Finland's Biotie Therapies .

19 Jan 2016

U.S. firm Acorda to buy Finland's Biotie for $363 million

HELSINKI, Jan 19 U.S. biotechnology company Acorda Therapeutics Inc. announced on Tuesday an agreed $363 million cash bid for all of the shares in Finland's Biotie Therapies.

19 Jan 2016

BRIEF-Biotie Therapies and Acorda Therapeutics enter into combination agreement

* Says Acorda Therapeutics and Biotie Therapies have entered into combination agreement

19 Jan 2016

UPDATE 2-Hedge fund manager Kyle Bass loses challenges to pharma patents

NEW YORK, Aug 24 Prominent hedge fund manager Kyle Bass's campaign to wipe out certain drug patents hit a roadblock on Monday when the U.S. Patent and Trademark Office declined to formally review two patents on Acorda Therapeutics Inc's flagship multiple sclerosis drug, Ampyra.

24 Aug 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Stock Traders Daily
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : Sadif Analytics Prime
$10.00
Provider : ValuEngine, Inc.
$25.00
Provider : Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks